Cellect Biotechnology Ltd (NASDAQ:APOP)

13.03
Delayed Data
As of Oct 22
 -1.41 / -9.76%
Today’s Change
6.60
Today|||52-Week Range
35.52
+50.81%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cellect Biotechnology Ltd have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a -7.90% decrease from the last price of 13.03.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Cellect Biotechnology Ltd. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
--
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
Growthannually -48.78%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.